2Baraka A. Test dose for prediction of mivacurium sensitivity in the patient with atypical plasma cholinesterase [ J ]. Anesthesiology,1995, 83:1371 - 1372.
3Mcleod K, Watson M J, Rawlins MD. Pharmacokinetics of pancuronium in patients with normal and impaired renal function [J]. Br J Anaesth, 1976, 48:341 -345.
4Slater RM, Pollard B J, Doran BRH. Prolonged neuromuscular blockade with vecuronium in renal failure [ J ]. Anaesthesia, 1998,43:250 -251.
5Cooper RA, Maddineni VR, Mirakhur RK, et al. Time course of neuromuscular effects and pharmacokinetics of rocuronium bromide (ORG9426) during isoflurane anaesthsia in patients with and without renal failure[J]. BrJ Anaesth, 1993, 71:222 -226.
6Fahey MR, Rupp SM, Canfell C, et al. Effect of renal failure on laudanosine excretion in man [J]. Br J Anaesth, 1985, 57:1049-1051.
7Boyd AH, Eastwood NB, Parker CJR, et al. Pharmacodynamics of the IR cis -1 ' R cis isomer of atracurium (51W89) in health and renal failure[ J ]. Br J Anaesth, 1995, 74:400 - 404.
8Sztark F, Cantini O, Badie CB, et al. Continuous infusion of cisatracurium in patients with renal dysfunction [ J ]. Anesthesiology,1999,91: A1037.
